FBRX Forte Biosciences, Inc.
Fundamentals / CIK 0001419041 / USDForte Biosciences, Inc. reported $205.7M in total assets and a net loss of $87.94M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FBRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$90.00M Operating profit
-
Net Income FY 2025-$87.94M GAAP bottom line
-
Diluted EPS FY 2025-$4.71 Split-adjusted
-
Free Cash Flow FY 2025-$72.03M Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$198.5M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | $36K | $18.04M | $41K | $49K |
| Research & Development | $57.65M | $20.71M | $21.86M | $5.59M | $13.85M | $10.00M | $45.30M | $51.08M | $29.11M | $27.22M |
| Total Operating Expenses | $70.66M | $36.60M | $32.49M | $13.90M | $21.49M | $46.28M | $4.06M | $63.89M | $37.67M | $31.74M |
| Operating Income | -$70.66M | -$36.60M | -$32.49M | -$13.90M | -$21.49M | -$46.28M | -$4.06M | -$45.85M | -$37.63M | -$31.69M |
| EBITDA | -$70.59M | -$36.56M | -$32.48M | -- | -$21.45M | -$46.23M | -$4.05M | -$45.23M | -$37.34M | -$31.43M |
| Interest Income | -- | -- | -- | -- | -- | -- | $1.56M | $1.53M | $595K | $215K |
| Interest Expense | -- | -- | -- | -- | -- | -- | $3.82M | $2.93M | $1.93M | $2.05M |
| Income Before Tax | -$68.34M | -$35.48M | -$31.48M | -- | -- | -- | -$63.52M | -$47.26M | -$38.93M | -$33.48M |
| Income Tax Expense | $1.04M | $0 | -- | -- | -- | -- | $1.0K | $1.70M | $1.0K | $1.0K |
| Net Income | -$69.38M | -$35.48M | -$31.48M | -$13.88M | -$21.71M | -$46.49M | -$4.07M | -$48.95M | -$38.93M | -$33.48M |
| Basic EPS | -$4.71 | -$12.17 | -$24.92 | -$20.00 | -$38.75 | -$158.00 | -$48.25 | -$61.00 | -$66.50 | -$380.50 |
| Diluted EPS | -$4.71 | -$12.17 | -$24.92 | -$20.00 | -$38.75 | -$158.00 | -$48.25 | -$61.00 | -$66.50 | -$380.50 |
| Basic Shares Outstanding | -- | -- | -- | 695.3K | 558.7K | 294.4K | 84.3K | 802.4K | 584.3K | 88.0K |
| Diluted Shares Outstanding | -- | -- | -- | 695.3K | 558.7K | 294.4K | 84.3K | 802.4K | 584.3K | 88.0K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $22.19M | $20.32M | $21.59M | $15.05M | $8.47M | $12.54M | $5.08M | $5.72M |
| Total Operating Expenses | $24.60M | $22.44M | $24.57M | $18.38M | $11.58M | $16.12M | $7.35M | $8.63M |
| Operating Income | -$24.60M | -$22.44M | -$24.57M | -$18.38M | -$11.58M | -$16.12M | -$7.35M | -$8.63M |
| EBITDA | -$24.58M | -$22.42M | -$24.55M | -$18.37M | -$11.56M | -$16.11M | -$7.34M | -$8.62M |
| Income Before Tax | -$23.14M | -$21.76M | -- | -- | -$11.25M | -$15.66M | -- | -- |
| Income Tax Expense | $193K | $373K | -- | -- | $0 | $0 | -- | -- |
| Net Income | -$23.33M | -$22.14M | -$24.79M | -$17.68M | -$11.25M | -$15.66M | -$7.16M | -$8.39M |
| Basic EPS | -$0.97 | -$1.24 | -- | -$0.99 | -$0.96 | -$1.37 | -- | -$4.54 |
| Diluted EPS | -$0.97 | -$1.24 | -- | -$0.99 | -$0.96 | -$1.37 | -- | -$4.54 |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $76.96M | $22.24M | $37.12M | $41.10M | $42.04M | $58.77M | $6.94M | $40.81M | $35.93M | $5.51M |
| Short-Term Investments | $0 | $36.12M | -- | $0 | -- | -- | $12.84M | $55.27M | $52.79M | $25.73M |
| Cash & Short-Term Investments | $76.96M | $58.40M | $37.12M | $41.10M | $42.04M | $58.77M | $21.80M | $96.10M | $88.72M | $31.25M |
| Total Current Assets | $80.59M | $61.35M | $38.33M | $41.51M | $42.52M | $59.90M | $7.51M | $97.75M | $90.63M | $32.46M |
| Property, Plant & Equipment, Net | $129K | $77K | $109K | -- | -- | $97K | $152K | $3.97M | $1.22M | $743K |
| Other Non-Current Assets | $2.06M | $138K | $544K | $486K | $786K | $1.24M | $0 | $1.36M | $227K | $2.15M |
| Total Non-Current Assets | $2.19M | $215K | $653K | $486K | $786K | $1.34M | $152K | $5.33M | $1.44M | $2.89M |
| Total Assets | $82.78M | $61.56M | $38.98M | $42.00M | $43.31M | $61.24M | $7.66M | $103.1M | $92.07M | $35.35M |
| Accounts Payable | $9.99M | $4.88M | $1.42M | $1.15M | $946K | $1.24M | $1.57M | $3.40M | $1.95M | $1.67M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $36K | $36K | $45K |
| Total Current Liabilities | $20.75M | $9.08M | $3.67M | $3.18M | $1.76M | $2.26M | $1.91M | $16.53M | $17.33M | $14.38M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $26.20M | $3.62M | $10.24M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | $36K | $68K |
| Other Non-Current Liabilities | $1.04M | -- | -- | -- | -- | -- | $81K | -- | -- | -- |
| Total Non-Current Liabilities | $1.04M | $0 | $0 | $0 | $0 | $0 | $15.40M | $28.40M | $3.66M | $13.97M |
| Total Liabilities | $21.79M | $9.08M | $3.67M | $3.18M | $1.76M | $2.26M | $17.31M | $44.94M | $20.99M | $28.36M |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | -- | $4.44M | $26.20M | $3.62M | $10.24M |
| Common Stock | $13K | $6.0K | $1.0K | $21K | $15K | $13K | $2.0K | $23K | $20K | $2.0K |
| Retained Earnings | -$223.4M | -$154.0M | -$118.5M | -$87.04M | -$73.17M | -$51.46M | -$4.97M | -$215.9M | -$166.9M | -$128.0M |
| Accumulated Other Comp. Income | $3.0K | $11K | $4.0K | -- | -- | -- | $10K | -$23K | -$34K | -- |
| Total Stockholders' Equity | $60.99M | $52.48M | $35.31M | $38.82M | $41.55M | $58.98M | -$4.77M | -$736K | $71.08M | -$124.4M |
| Total Equity | $60.99M | $52.48M | $35.31M | $38.82M | $41.55M | $58.98M | -$4.77M | -$736K | $71.08M | -$124.4M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $49.63M | $58.22M | $76.96M | $93.41M | $106.1M | $45.86M | $22.24M | $16.36M |
| Short-Term Investments | $148.8M | -- | $0 | -- | -- | -- | $36.12M | -- |
| Cash & Short-Term Investments | $198.5M | $58.22M | $76.96M | $93.41M | $106.1M | $45.86M | $58.40M | $16.36M |
| Total Current Assets | $203.1M | $65.11M | $80.59M | $95.41M | $107.6M | $47.16M | $61.35M | $17.67M |
| Property, Plant & Equipment, Net | $90K | $110K | $129K | $148K | $110K | $125K | $77K | $86K |
| Other Non-Current Assets | $2.55M | $2.00M | $2.06M | $1.53M | $57K | $176K | $138K | $192K |
| Total Non-Current Assets | $2.64M | $2.11M | $2.19M | $1.68M | $167K | $301K | $215K | $278K |
| Total Assets | $205.7M | $67.22M | $82.78M | $97.09M | $107.8M | $47.46M | $61.56M | $17.95M |
| Accounts Payable | $14.01M | $13.08M | $9.99M | $5.49M | $5.30M | $5.02M | $4.88M | $5.16M |
| Total Current Liabilities | $20.29M | $23.65M | $20.75M | $12.99M | $9.17M | $9.03M | $9.08M | $8.58M |
| Other Non-Current Liabilities | $1.66M | $1.48M | $1.04M | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $1.66M | $1.48M | $1.04M | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $21.95M | $25.12M | $21.79M | $12.99M | $9.17M | $9.03M | $9.08M | $8.58M |
| Common Stock | $21K | $14K | $13K | $13K | $12K | $6.0K | $6.0K | $1.0K |
| Retained Earnings | -$268.8M | -$245.5M | -$223.4M | -$198.6M | -$180.9M | -$169.7M | -$154.0M | -$146.8M |
| Accumulated Other Comp. Income | -$54K | -$4.0K | $3.0K | -$6.0K | -- | -- | $11K | $1.0K |
| Total Stockholders' Equity | $183.8M | $42.10M | $60.99M | $84.10M | $98.61M | $38.43M | $52.48M | $9.37M |
| Total Equity | $183.8M | $42.10M | $60.99M | $84.10M | $98.61M | $38.43M | $52.48M | $9.37M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$69.38M | -$35.48M | -$31.48M | -$13.88M | -$21.71M | -$46.49M | -$4.07M | -$48.95M | -$38.93M | -$33.48M |
| Depreciation & Amortization | $64K | $39K | $9.0K | -- | $36K | $54K | $11K | $625K | $292K | $255K |
| Stock-Based Compensation | $6.26M | $3.10M | $3.28M | $4.01M | $4.21M | $956K | $36K | $6.87M | $4.45M | $1.32M |
| Change in Payables | $5.54M | $3.02M | $271K | $207K | -$294K | -$369K | $976K | $1.26M | $304K | $586K |
| Operating Cash Flow | -$50.88M | -$30.75M | -$28.71M | -$8.19M | -$16.68M | -$18.42M | -$2.77M | -$34.47M | -$31.13M | -$29.54M |
| Capital Expenditure | -$116K | -$37K | -$88K | -- | -- | -- | -$162K | -$1.97M | -$655K | -$525K |
| Free Cash Flow | -$51.00M | -$30.78M | -$28.79M | -- | -- | -- | -$2.93M | -$36.44M | -$31.79M | -$30.06M |
| Purchases of Investments | $0 | -$35.96M | -$9.96M | -- | -- | -- | -$51.16M | -$70.75M | -$70.80M | -$23.00M |
| Investing Cash Flow | $36.23M | -$35.99M | $47K | -- | -- | $3.58M | -$162K | -$4.19M | -$27.71M | $24.57M |
| Common Stock Issued | $1.78M | $0 | -- | $7.23M | -- | $66.70M | $551K | $661K | $507K | $10K |
| Financing Cash Flow | $69.36M | $51.86M | $24.68M | $7.24M | -$44K | $66.67M | $4.86M | $43.54M | $89.26M | $2.33M |
| Net Change in Cash | $54.71M | -$14.88M | -$3.98M | -$944K | -$16.72M | $51.83M | $1.92M | $4.88M | $30.42M | -$2.64M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$23.33M | -$22.14M | -$24.79M | -$17.68M | -$11.25M | -$15.66M | -$7.16M | -$8.39M |
| Depreciation & Amortization | $20K | $19K | $19K | $17K | $15K | $13K | $10K | $10K |
| Stock-Based Compensation | $3.67M | $3.18M | $1.66M | $1.48M | $1.50M | $1.62M | $697K | $791K |
| Change in Payables | $388K | $3.10M | $4.50M | $558K | -$90K | $578K | -$714K | -$116K |
| Operating Cash Flow | -$22.70M | -$18.81M | -$16.47M | -$14.00M | -$10.06M | -$10.36M | -$10.01M | -$8.13M |
| Capital Expenditure | $0 | $0 | $0 | -$55K | $0 | -$61K | -$31K | $0 |
| Free Cash Flow | -$22.70M | -$18.81M | -$16.47M | -$14.05M | -$10.06M | -$10.42M | -$10.04M | -$8.13M |
| Investing Cash Flow | -$147.8M | $0 | $0 | -$55K | $0 | $36.29M | -$35.99M | $0 |
| Financing Cash Flow | $161.9M | $74K | $9.0K | $1.32M | $70.35M | -$2.32M | $51.88M | -$2.0K |
| Net Change in Cash | -$8.59M | -$18.73M | -$16.46M | -$12.73M | $60.29M | $23.61M | $5.88M | -$8.13M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -- | -- | -- | -11288.9% | -254.2% | -91775.6% | -64673.5% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -11302.8% | -271.4% | -94948.8% | -68322.4% |
| Return on Equity (ROE) | -113.7% | -67.6% | -89.1% | -35.8% | -52.2% | -78.8% | -- | -- | -54.8% | -- |
| Return on Assets (ROA) | -83.8% | -57.6% | -80.7% | -33.0% | -50.1% | -75.9% | -53.1% | -47.5% | -42.3% | -94.7% |
| Current Ratio | 3.88x | 6.76x | 10.45x | 13.06x | 24.19x | 26.52x | 3.93x | 5.91x | 5.23x | 2.26x |
| Quick Ratio | 3.71x | 6.43x | 10.13x | 12.93x | 23.92x | 26.01x | 11.40x | 5.81x | 5.12x | 2.17x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | -- | 0.05x | -- |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -- | -99.8% | +43890.2% | -16.3% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -47.8% | -180.2% | -113.7% | -61.5% | -43.0% | -113.8% | -67.6% | -365.1% |
| Return on Assets (ROA) | -42.7% | -112.8% | -83.8% | -53.3% | -39.4% | -92.1% | -57.6% | -190.5% |
| Current Ratio | 10.01x | 2.75x | 3.88x | 7.34x | 11.74x | 5.22x | 6.76x | 2.06x |
| Quick Ratio | 9.78x | 2.46x | 3.71x | 7.19x | 11.58x | 5.08x | 6.43x | 1.91x |